Exclusive Research License definition

Exclusive Research License has the meaning set forth in Section 3.1.1.
View Source
Exclusive Research License shall have the meaning set forth in Section 2.1. [*] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
View Source
Exclusive Research License has the meaning set forth in Section 5.1(A). “Executive Officers” means (A) for Genmab, of Genmab (or if such position no longer exists, another C-level senior executive officer designated by ▇▇▇▇▇▇ and having the requisite decision-making authority and expertise within Genmab to make decisions related to the Dispute so referred to such designee) and (B) for Centessa, of Centessa (or his/her designee having the requisite decision-making authority and expertise within Centessa to make decisions related to the Dispute so referred to such designee). If the position of any of the Executive Officers identified in this definition no longer exists due to a corporate reorganization, corporate restructuring or the like that results in the elimination of the identified position, the applicable Executive Officer shall be replaced with another executive officer with responsibilities and seniority comparable to the eliminated Executive Officer. “FDA” means the United States Food and Drug Administration or any successor agency thereto.
View Source

Examples of Exclusive Research License in a sentence

  • The Exclusive Research License, Commercial License, PlaNet Genes License, Non-Assert License and the ROFO described in Section 3.1.5 (Rights of First Offer) of the Agreement, covering Collaboration Hits and their respective Collaboration Hit Homologs, PlaNet ▇▇▇▇ ▇▇▇▇▇▇, RePack Recommendations and G2P Recommendations, shall in each case be limited solely to Corn.

  • Options and Licenses; Sublicensing 14 3.1 Non-Exclusive Research License and Cross-License 14 3.2 Option to Acquire an Exclusive Research License 14 3.3 Exclusive Research Targets 14 3.4 Option to Acquire Development Rights 16 3.5 Exclusive Commercial License 16 3.6 Grant-Back License 16 3.7 Sublicensing 16 3.8 Contractors 17 4.

  • Prior to the [*] anniversary of the Restatement Date, and subject to clearance of the gate-keeping procedure set forth in Section 2.4, Miragen shall have the right to nominate and include in the Exclusive Research License and Product License one additional Target [*] of Existing Targets (“Existing Target [*] 4”).

  • If either party becomes aware of any infringement in a Monsanto Crop of the Evogene Patent Rights or assertion thereof in respect of a Collaboration Hit Homolog, Special Collaboration Hit, PlaNet ▇▇▇▇ ▇▇▇▇▇ or RePack Recommendation as to which the Exclusive Research License, Commercial License, PlaNet Genes License and/or Non-Assert *** Confidential treatment has been requested for redacted portions of this exhibit.

  • In addition, the Covered Vegetables, which were part of the “Monsanto Crops” until the Signing Date, shall be excluded from the Monsanto Crops for purposes of the Exclusive Research License, the Commercial License and the Non-Assert License, as of the Effective Date.